These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 18473901)
1. Molecular targets of rheumatoid arthritis. Okamoto H; Hoshi D; Kiire A; Yamanaka H; Kamatani N Inflamm Allergy Drug Targets; 2008 Mar; 7(1):53-66. PubMed ID: 18473901 [TBL] [Abstract][Full Text] [Related]
2. Molecular aspects of rheumatoid arthritis: role of transcription factors. Okamoto H; Cujec TP; Yamanaka H; Kamatani N FEBS J; 2008 Sep; 275(18):4463-70. PubMed ID: 18662303 [TBL] [Abstract][Full Text] [Related]
3. [Rheumatoid arthritis: new developments in the pathogenesis with special reference to synovial fibroblasts]. Seemayer CA; Distler O; Kuchen S; Müller-Ladner U; Michel BA; Neidhart M; Gay RE; Gay S Z Rheumatol; 2001 Oct; 60(5):309-18. PubMed ID: 11759230 [TBL] [Abstract][Full Text] [Related]
4. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. Taylor PC; Peters AM; Paleolog E; Chapman PT; Elliott MJ; McCloskey R; Feldmann M; Maini RN Arthritis Rheum; 2000 Jan; 43(1):38-47. PubMed ID: 10643698 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells. Matsuoka N; Eguchi K; Kawakami A; Tsuboi M; Kawabe Y; Aoyagi T; Nagataki S Clin Exp Immunol; 1996 Jun; 104(3):501-8. PubMed ID: 9099936 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis. Smeets TJ; Barg EC; Kraan MC; Smith MD; Breedveld FC; Tak PP Ann Rheum Dis; 2003 Jul; 62(7):635-8. PubMed ID: 12810425 [TBL] [Abstract][Full Text] [Related]
7. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Feldmann M; Maini RN Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034 [TBL] [Abstract][Full Text] [Related]
8. Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Isomäki P; Punnonen J Ann Med; 1997 Dec; 29(6):499-507. PubMed ID: 9562516 [TBL] [Abstract][Full Text] [Related]
9. Pannus invasion and cartilage degradation in rheumatoid arthritis: involvement of MMP-3 and interleukin-1beta. Ainola MM; Mandelin JA; Liljeström MP; Li TF; Hukkanen MV; Konttinen YT Clin Exp Rheumatol; 2005; 23(5):644-50. PubMed ID: 16173240 [TBL] [Abstract][Full Text] [Related]
10. [Rheumatoid arthritis and cytokines]. Kaneko S; Kondo Y; Yokosawa M; Sumida T Nihon Rinsho; 2016 Jun; 74(6):913-8. PubMed ID: 27311178 [TBL] [Abstract][Full Text] [Related]
11. Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis. Koenders MI; Joosten LA; van den Berg WB Ann Rheum Dis; 2006 Nov; 65 Suppl 3(Suppl 3):iii29-33. PubMed ID: 17038468 [TBL] [Abstract][Full Text] [Related]
12. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. Iwamoto T; Okamoto H; Toyama Y; Momohara S FEBS J; 2008 Sep; 275(18):4448-55. PubMed ID: 18662305 [TBL] [Abstract][Full Text] [Related]
13. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model. Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156 [TBL] [Abstract][Full Text] [Related]
14. Thymoquinone inhibits TNF-α-induced inflammation and cell adhesion in rheumatoid arthritis synovial fibroblasts by ASK1 regulation. Umar S; Hedaya O; Singh AK; Ahmed S Toxicol Appl Pharmacol; 2015 Sep; 287(3):299-305. PubMed ID: 26134265 [TBL] [Abstract][Full Text] [Related]
15. Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium. Harigai M; Hara M; Yoshimura T; Leonard EJ; Inoue K; Kashiwazaki S Clin Immunol Immunopathol; 1993 Oct; 69(1):83-91. PubMed ID: 8403545 [TBL] [Abstract][Full Text] [Related]
16. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663 [TBL] [Abstract][Full Text] [Related]
17. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium. Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402 [TBL] [Abstract][Full Text] [Related]
18. Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. Chabaud M; Page G; Miossec P J Immunol; 2001 Nov; 167(10):6015-20. PubMed ID: 11698482 [TBL] [Abstract][Full Text] [Related]
19. Reduction of inflammatory cytokines and prostaglandin E2 by IL-13 gene therapy in rheumatoid arthritis synovium. Woods JM; Katschke KJ; Tokuhira M; Kurata H; Arai KI; Campbell PL; Koch AE J Immunol; 2000 Sep; 165(5):2755-63. PubMed ID: 10946307 [TBL] [Abstract][Full Text] [Related]
20. Immunohistological and functional analysis of adhesion molecule expression in the rheumatoid synovial lining layer. Implications for synovial lining cell destruction. van Dinther-Janssen AC; Kraal G; van Soesbergen RM; Scheper RJ; Meijer CJ J Rheumatol; 1994 Nov; 21(11):1998-2004. PubMed ID: 7532716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]